← All indications
Calculi
An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.
Subtype terms (4)
More specific conditions that are subtypes of Calculi in the MeSH hierarchy.
- Dental Calculus
4 drugs (2 approved, 2 experimental)
- Gallstones
35 drugs (25 approved, 10 experimental)
- Salivary Calculi
- Urinary Calculi
17 drugs (16 approved, 1 experimental)
Drugs by status
Phase 4 trials (3)
Phase 3 trials (2)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (31)
- Grunenthal
- Pfizer
- Baxalta
- Dong-A Pharmaceutical
- Hamad Medical Corporation
- Ouiheng International Healthcare Co., Ltd
- University of Roma La Sapienza
- Changhai Hospital
- Chulalongkorn University
- Hahnemann University Hospital
- Mansoura University
- McMaster University
- Pontificia Universidad Catolica de Chile
- Siriraj Hospital
- University of Iowa
- Mayo Clinic
- Chongqing Medical University
- Prince of Songkla University
- University of British Columbia
- University of Minnesota
- Hebrew University
- University of Sao Paulo
- Chiangmai University
- University of Sherbrooke
- University of Western Ontario
- Sungkyunkwan University
- Yeshiva University
- University of Helsinki
- The Cleveland Clinic
- University Clermont Auvergne
- +1 more
Organization Involved with Phase 3 Indications (11)
- Sanofi
- Yamanouchi Pharmaceuticals
- National Center for Research Resources (NCRR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Navy
- Northwell Health
- Singapore General Hospital
- University of Rennes
- Government of France
- Assistance Publique - Hôpitaux de Paris
- The University of Texas, Dallas
Organization Involved with Phase 2 Indications (10)
Organization Involved with Other Experimental Indications (9)